Products for Research Use Only
RegisterLogin

Nerelimomab

CAT: 0804-HY-P99753Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99753Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Nerelimomab (BAYX1351) is an anti-TNF-α antibody. Nerelimomab can be used for research of sepsis[1][2].
CAS Number
162774-06-3
Product Name Alternative
BAYX1351
UNSPSC
12352203
Target
TNF Receptor
Type
Inhibitory Antibodies
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/nerelimomab.html
Solubility
10 mM in DMSO
Smiles
[Nerelimomab]
References & Citations
[1]Schlag G, et al. Anti-tumor necrosis factor antibody treatment of recurrent bacteremia in a baboon model. Shock. 1994 Jul;2 (1) :10-8; discussion 19-22. |[2]Cohen J, et al. INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group. Crit Care Med. 1996 Sep;24 (9) :1431-40.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported

Alternative Products

CatalogName
abx831724-01Nerelimomab
GTR18337666Nerelimomab Antibody
DHB94406Research Grade Nerelimomab
KBI1498KRIBIOLISA™ Nerelimomab ELISA
E55B0270Nerelimomab (Reference antibody)
ICH5708-1mgNerelimomab Biosimilar - Research Grade
GTR18697994-01Nerelimomab Mouse Monoclonal Antibody
A134835Nerelimomab Biosimilar (Monoclonal, IgG1-nd)
YR1205-01Anti-Human TNFA Recombinant Antibody (Nerelimomab)
PX-TA1219-01Nerelimomab Biosimilar - Anti-TNFSF2, TNF-alpha, TNFA mAb - Research Grade

Popular Products